IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel disease
Current Molecular Pharmacology · 2026 · 19 (1) · 1-13
DOI: 10.1016/j.cmp.2026.02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Shuting Yang und 13 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Program of Suzhou, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Science and Technology Program of Suzhou
- National Natural Science Foundation of China
Zitieren
APA
Yang, S., Jiang, T., Shi, Z., Zhou, F., Yu, H., Huang, J., Li, X., Guo, J., Zhao, H., Zhang, Q., Wang, B., Zhou, J., Zhang, Y., & Zhou, G. (2026). IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel disease. Current Molecular Pharmacology, 19(1), 1-13. https://doi.org/10.1016/j.cmp.2026.02.001
Vancouver
Yang S, Jiang T, Shi Z, Zhou F, Yu H, Huang J, et al. IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel disease. Current Molecular Pharmacology. 2026;19(1):1-13. doi:10.1016/j.cmp.2026.02.001
BibTeX
@article{Yang2026,
author = {Yang, Shuting and Jiang, Tingwang and Shi, Zhiliang and Zhou, Fang and Yu, Hongshuang and Huang, Jiefang and Li, Xuefeng and Guo, Jian and Zhao, Hongmei and Zhang, Qi and Wang, Bei and Zhou, Jieru and Zhang, Yanyun and Zhou, Guoqiang},
title = {IGFBP1 is a potential monitoring biomarker of disease activity in elderly patients with inflammatory bowel disease},
journal = {Current Molecular Pharmacology},
year = {2026},
volume = {19},
number = {1},
pages = {1--13},
doi = {10.1016/j.cmp.2026.02.001}
}
EUVIMED